EndoGastric Solutions raises $30.5M from existing and new investors to expand commercialization of TIF GERD treatment
EndoGastric Solutions raised $30.5 million from existing and new investors to scale commercialization of its on-market treatment for chronic acid reflux (GERD), aiming to expand access to its TIF procedure for millions of patients.